Food retailers and manufacturers will ‘make the healthy choice the easy choice’ in a world-first partnership between government and industry to tackle the obesity epidemic and ease pressure on the NHS as part of the Plan for Change. 

Childhood obesity is set to worsen across England, with new projections revealing that more than half of all 10- and 11-year-olds in nine local authority areas will be living with overweight or obesity by 2035.

With more than a third of adults in parts of Worcestershire living with obesity, the county’s Director of Public Health, Dr Lisa McNally has called for a shift away from finger-pointing and shame – and towards practical, community-based support.

A new study has identified key gaps in current genetic testing approaches for obesity, suggesting that more comprehensive analysis is needed to identify individuals with a genetic predisposition to the condition. The findings highlight the value of whole-exome sequencing over existing obesity gene panels and call for a rethink of current testing criteria.

A London borough is set to introduce a ban on junk food advertising in a move aimed at tackling rising rates of obesity and diabetes.

Full data from two major Phase 3 trials of Novo Nordisk’s investigational weight-loss treatment, CagriSema, show that most side effects were mild to moderate, with positive outcomes reported for weight reduction and blood sugar control.

Mounjaro, the weekly weight-loss injection also known as tirzepatide, will be available through GP surgeries in England from today. However, access to the drug is limited to people who meet tight eligibility criteria, as the NHS takes a phased approach to manage demand and resources.

Novo Nordisk recently presented the results from the phase 3b STEP UP trial for weight management in adults living with obesity without diabetes at the American Diabetes Association (ADA) Scientific Sessions, in Chicago.

Teenage boys who are overweight could be passing on harmful genetic changes to their future children, increasing their risk of conditions such as obesity and asthma, according to new research.

Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of researchers has identified a gene that appears to be key for regulating food intake.

Women prescribed GLP-1 weight-loss medications urged to use effective contraception as MHRA highlights reproductive health concerns

A new digital tool aimed at children living with severe obesity is set to be piloted across 15 specialist NHS clinics in England.

The number of US adolescents being prescribed the weight-loss medication Wegovy has surged by 50 per cent in the past year, according to new data, as families and healthcare professionals increasingly consider GLP-1 therapies as part of obesity treatment.

A new integrative review explores how healthcare professionals can be supported to reduce weight bias in clinical practice – a key step in delivering compassionate, personalised care for people living with obesity.

A major new report has warned that nearly half a billion adolescents worldwide will be living with overweight or obesity by 2030, marking a dramatic escalation in the global health crisis facing young people.

A large new study has found that people living with obesity and type 2 diabetes who are treated with GLP-1 receptor agonists have a similar risk of developing obesity-related cancers as those who undergo bariatric metabolic surgery.

The Oral Health Foundation is calling on the government to introduce mandatory front-of-pack sugar warnings, enforce consistent naming for added sugars across all products and lead a public education campaign to help people recognise and reduce their sugar intake.

A major new systematic review has been published providing much-needed guidance on how obesity affects the way antibiotics are processed in the body – and how dosing should be adjusted to ensure effectiveness.

Adults who developed severe obesity before the age of 18 are nearly three times more likely than those who developed the condition later to be subjected to severe experienced weight stigma (EWS), a study led by UT Southwestern Medical Center researchers shows.

Northern Ireland is set to introduce its first ever regional obesity management service, following an announcement by Health Minister Mike Nesbitt.